Clinical Trials Logo

Cancers With RET Alterations clinical trials

View clinical trials related to Cancers With RET Alterations.

Filter by:
  • None
  • Page 1

NCT ID: NCT03052569 No longer available - Clinical trials for Cancers With RET Alterations

Expanded Access to RXDX-105 for Cancers With RET Alterations

Start date: n/a
Phase:
Study type: Expanded Access

Expanded access to RXDX-105 will be given to patients with cancers harboring RET alterations who have not received TKIs that target RET alterations, who do not qualify for participation in, or who are otherwise unable to access, an ongoing clinical trial for RXDX-105.